Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: A longitudinal electronic monitoring study

AIDS Patient Care and STDs

Volumn 27, Issue 4, 2013, Pages 208-210

  Gertsch, Aurélie ^a,b   Michel, Odile ^a   Locatelli, Isabella ^b,c   Bugnon, Olivier ^a,b   Rickenbach, Martin ^d   Cavassini, Matthias ^e   Schneider, Marie Paule ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d Mont Paisible 16   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;

ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; CHILDBIRTH; DRUG MONITORING; ELECTRONIC MEDICAL RECORD; EXTERNAL VALIDITY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LETTER; MENSTRUATION; MOTHER; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREGNANCY; PREGNANT WOMAN; PUERPERIUM; RETROSPECTIVE STUDY; SELF REPORT; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVALS; ELECTRICAL EQUIPMENT AND SUPPLIES; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LOGISTIC MODELS; LONGITUDINAL STUDIES; MEDICATION ADHERENCE; POSTPARTUM PERIOD; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; SWITZERLAND; TIME FACTORS;

EID: 84876100453     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2013.0005     Document Type: Letter

References (11)

1. Kreitchmann R, Harris DR, Kakehasi F, et al. Antiretroviral adherence during pregnancy and postpartum in Latin America. AIDS Patient Care STDs 2012;26:486-495.
2. Transmission PoToH-IPWaPoP. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. 2012. http://aidsinfo .nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf (last accessed October 30, 2012).
3. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73:691-705.
4. Krummenacher I, Cavassini M, Bugnon O, Schneider MP. An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care 2011;23:550-561.
5. Ciambrone D, Loewenthal HG, Bazerman LB, Zorilla C, Urbina B, Mitty JA. Adherence among women with HIV infection in Puerto Rico: The potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women. Women Health 2006;44:61-77.
6. Nassali M, Nakanjako D, Kyabayinze D, Beyeza J, Okoth A, Mutyaba T. Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: Adherence to the postnatal PMTCT program. AIDS Care 2009;21:1124-1131.
7. Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-, middle and high income countries: A systematic review and meta-analysis. AIDS 2012;26:2039-2052.
8. Mellins CA, Chu C, Malee K, et al. Adherence to antiretroviral treatment among pregnant and postpartum HIVinfected women. AIDS Care 2008;20:958-968.
9. Ickovics JR, Wilson TE, Royce RA, et al. Prenatal and postpartum zidovudine adherence among pregnant women with HIV: Results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. J Acquir Immune Defic Syndr 2002;30:311-315. (Pubitemid 34774079)
10. Cohn SE, Umbleja T, Mrus J, Bardeguez AD, Andersen JW, Chesney MA. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: Adherence analysis A5084. AIDS Patient Care STDs 2008;22:29-40.
11. Naumova EN, Must A, Laird NM. Tutorial in Biostatistics: Evaluating the impact of 'critical periods' in longitudinal studies of growth using piecewise mixed effects models. Int J Epidemiol 2001;30:1332-1341. (Pubitemid 34134286)